Your browser doesn't support javascript.
loading
The p53 C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domain.
Laptenko, Oleg; Shiff, Idit; Freed-Pastor, Will; Zupnick, Andrew; Mattia, Melissa; Freulich, Ella; Shamir, Inbal; Kadouri, Noam; Kahan, Tamar; Manfredi, James; Simon, Itamar; Prives, Carol.
Afiliación
  • Laptenko O; Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
  • Shiff I; Department of Microbiology and Molecular Genetics, Hebrew University Medical School, IMRIC, Jerusalem 91120, Israel.
  • Freed-Pastor W; Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
  • Zupnick A; Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
  • Mattia M; Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
  • Freulich E; Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
  • Shamir I; Department of Microbiology and Molecular Genetics, Hebrew University Medical School, IMRIC, Jerusalem 91120, Israel.
  • Kadouri N; Department of Microbiology and Molecular Genetics, Hebrew University Medical School, IMRIC, Jerusalem 91120, Israel.
  • Kahan T; Department of Microbiology and Molecular Genetics, Hebrew University Medical School, IMRIC, Jerusalem 91120, Israel.
  • Manfredi J; Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA.
  • Simon I; Department of Microbiology and Molecular Genetics, Hebrew University Medical School, IMRIC, Jerusalem 91120, Israel. Electronic address: itamarsi@ekmd.huji.ac.il.
  • Prives C; Department of Biological Sciences, Columbia University, New York, NY 10027, USA. Electronic address: clp3@columbia.edu.
Mol Cell ; 57(6): 1034-1046, 2015 Mar 19.
Article en En | MEDLINE | ID: mdl-25794615
DNA binding by numerous transcription factors including the p53 tumor suppressor protein constitutes a vital early step in transcriptional activation. While the role of the central core DNA binding domain (DBD) of p53 in site-specific DNA binding has been established, the contribution of the sequence-independent C-terminal domain (CTD) is still not well understood. We investigated the DNA-binding properties of a series of p53 CTD variants using a combination of in vitro biochemical analyses and in vivo binding experiments. Our results provide several unanticipated and interconnected findings. First, the CTD enables DNA binding in a sequence-dependent manner that is drastically altered by either its modification or deletion. Second, dependence on the CTD correlates with the extent to which the p53 binding site deviates from the canonical consensus sequence. Third, the CTD enables stable formation of p53-DNA complexes to divergent binding sites via DNA-induced conformational changes within the DBD itself.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: ADN / Proteína p53 Supresora de Tumor Límite: Humans Idioma: En Revista: Mol Cell Asunto de la revista: BIOLOGIA MOLECULAR Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: ADN / Proteína p53 Supresora de Tumor Límite: Humans Idioma: En Revista: Mol Cell Asunto de la revista: BIOLOGIA MOLECULAR Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos